Learn more at LeadIQ.com

Insights

Gathering insights about THERAVECTYS…

Similar companies to THERAVECTYS

THERAVECTYS Tech Stack

THERAVECTYS uses 8 technology products and services including WordPress Super Cache, MySQL, Twitter Emoji (Twemoji), and more. Explore THERAVECTYS's tech stack below.

WordPress Super Cache
Caching
MySQL
Database
Twitter Emoji (Twemoji)
Font Scripts
yepnope.js
Javascript Frameworks
Modernizr
Javascript Libraries
Google Maps
Maps
RSS
Miscellaneous
IIS
Web Servers

Media & News

TheraVectys SA received financing of $20M in funding round on Feb 11th '21.
THERAVECTYS, the world leading pioneer in lentiviral vector technology, announced today a fully subscribed $20M funding round.
Feb 10, 2021 | www.theravectys.com
TheraVectys SA hires Alain Clergeot as Chief Executive Officer.
THERAVECTYS, a French biotech company specialized in lentiviral vector -based therapeutic vaccines and other immunotherapies, is pleased to announce the appointment of Alain Clergeot, MD, as Chief Executive Officer.
Dec 14, 2014 | www.theravectys.com
TheraVectys SA hires Alain Clergeot as Chief Executive Officer.
THERAVECTYS, a French biotech company specialized in lentiviral vector -based therapeutic vaccines and other immunotherapies, is pleased to announce the appointment of Alain Clergeot, MD, as Chief Executive Officer.
Jul 24, 2014 | www.theravectys.com
TheraVectys SA hires Alain Clergeot as Chief Executive Officer.
THERAVECTYS, a French biotech company specialized in lentiviral vector -based therapeutic vaccines and other immunotherapies, is pleased to announce the appointment of Alain Clergeot, MD, as Chief Executive Officer.
Jul 24, 2014 | www.theravectys.com

THERAVECTYS's Email Address Formats

THERAVECTYS uses at least 1 format(s):

THERAVECTYS Email Formats	Example	Percentage
FLast@theravectys.com	JDoe@theravectys.com	44%
First.Last@theravectys.com	John.Doe@theravectys.com	11%
FMiddleLast@theravectys.com	JMichaelDoe@theravectys.com	1%
FLast@theravectys.com	JDoe@theravectys.com	44%

Frequently Asked Questions

Where is THERAVECTYS's headquarters located?

THERAVECTYS's main headquarters is located at 28, Rue du Docteur Roux Paris, Île-de-France 75015 FR. The company has employees across 1 continents, including Europe.

What is THERAVECTYS's phone number?

You can contact THERAVECTYS's main corporate office by phone at

+33-1-43-90-1****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is THERAVECTYS's official website and social media links?

THERAVECTYS's official website is theravectys.com and has social profiles on LinkedIn.

How much revenue does THERAVECTYS generate?

As of June 2024, THERAVECTYS's annual revenue reached $3.8M.

What is THERAVECTYS's SIC code NAICS code?

THERAVECTYS's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does THERAVECTYS have currently?

As of June 2024, THERAVECTYS has approximately 18 employees across 1 continents, including Europe. Key team members include Chief Representative: A. H.Senior VP, Business Development: D. B.Clinical Operations Director: E. B.. Explore THERAVECTYS's employee directory with LeadIQ.

What industry does THERAVECTYS belong to?

THERAVECTYS operates in the Biotechnology Research industry.

What technology does THERAVECTYS use?

THERAVECTYS's tech stack includes WordPress Super CacheMySQLTwitter Emoji (Twemoji)yepnope.jsModernizrGoogle MapsRSSIIS.

What is THERAVECTYS's email format?

THERAVECTYS's email format typically follows the pattern of . Find more THERAVECTYS email formats with LeadIQ.

How much funding has THERAVECTYS raised to date?

As of June 2024, THERAVECTYS has raised $20M in funding. The last funding round occurred on Feb 08, 2021 for $20M.

When was THERAVECTYS founded?

THERAVECTYS was founded in 2005.

THERAVECTYS

THERAVECTYS

Biotechnology ResearchÎle-de-France, France11-50 Employees

Based in Paris and in the USA, TheraVectys is an immunotherapy company spun off from the Institut Pasteur created in 2005 by Dr. Pierre Charneau.

TheraVectys is pioneering the application of novel lentiviral vector technology to address most of unmet and critical medical needs.

By creating the only Joint-Laboratory between a private company and the Institut Pasteur in Paris, TheraVectys develops an extensive pipeline of vaccine candidates to drive the widespread treatment and prevention of cancer and infectious diseases.

Leveraging our proprietary technology platform, and the extensive virology expertise of the Institut Pasteur, TheraVectys provides a robust and highly effective transfection mechanism to elicit a potent and targeted immune response previously unseen.

Company Overview

Headquarters: 28, Rue du Docteur Roux Paris, Île-de-France 75015 FR
Phone number: ✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+33-1-43-90-1****
Website: theravectys.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2005
Employees: 11-50

Media & News

Funding & Financials

$20M
THERAVECTYS has raised a total of $20M of funding over 4 rounds. Their latest funding round was raised on Feb 08, 2021 in the amount of $20M.
$10M
THERAVECTYS's revenue is in the range of $10M

Funding & Financials

$20M
THERAVECTYS has raised a total of $20M of funding over 4 rounds. Their latest funding round was raised on Feb 08, 2021 in the amount of $20M.
$10M
THERAVECTYS's revenue is in the range of $10M

Company Leadership

A. H.
Chief Representative
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. B.
Senior VP, Business Development
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. B.
Clinical Operations Director
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. N.
Senior Scientist / Project Leader In Vaccine Development
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. S.
General Manager
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

J. C.
General Manager
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. D.
Senior Scientist / Immuno Oncology Vaccine Development
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. N.
Assistante Ingénieur De Bioproduction
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. D.
Chef De Projet
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. B.
Responsable Administratif Et Financier
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for THERAVECTYS and Millions of Other Companies
Sign up for full access to THERAVECTYS information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.